Consolidated statement of changes in equity - EUR (€) € in Thousands |
Total |
IPO |
RSU |
Performance Options |
Allego Holding shareholders |
PIPE financing |
Total |
Total
IPO
|
Total
RSU
|
Total
Allego Holding shareholders
|
Total
PIPE financing
|
Share capital |
Share capital
IPO
|
Share capital
RSU
|
Share capital
Performance Options
|
Share capital
Allego Holding shareholders
|
Share capital
PIPE financing
|
Share premium |
Share premium
IPO
|
Share premium
RSU
|
Share premium
Performance Options
|
Share premium
Allego Holding shareholders
|
Share premium
PIPE financing
|
Reserves |
Accumulated deficit |
Accumulated deficit
RSU
|
Accumulated deficit
Performance Options
|
Non-controlling interests |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning balance at Dec. 31, 2021 | € (76,652) | € (76,652) | € 1 | € 61,888 | € 4,195 | € (142,736) | ||||||||||||||||||||||
| Loss for the year | (305,292) | (304,778) | (304,778) | € (514) | ||||||||||||||||||||||||
| Other comprehensive income/(loss) for the year | (10,198) | (10,198) | (10,169) | (29) | ||||||||||||||||||||||||
| Total comprehensive income/(loss) for the year | (315,490) | (314,976) | (10,169) | (304,807) | (514) | |||||||||||||||||||||||
| Other changes in reserves | 0 | 0 | (886) | 886 | ||||||||||||||||||||||||
| Equity contribution (Allego Holding shareholders) | € 101,931 | € 101,931 | € 28,311 | € 73,620 | ||||||||||||||||||||||||
| Equity contribution (Spartan shareholders) | 87,597 | 87,597 | 1,789 | 85,808 | ||||||||||||||||||||||||
| Equity contribution (PIPE financing) and Transaction costs related to issuance of ordinary shares in exchange of Public Warrants | € 132,690 | € 132,690 | € 1,800 | € 130,890 | ||||||||||||||||||||||||
| Equity contribution (Private warrants exercise) and Issuance of shares in exchange of Public Warrants | 13,854 | 13,854 | 160 | 13,694 | ||||||||||||||||||||||||
| Non-controlling interests on acquisition of subsidiary | 1,259 | 1,259 | ||||||||||||||||||||||||||
| Share-based payment expenses | 82,569 | 82,569 | 82,569 | |||||||||||||||||||||||||
| Ending balance at Dec. 31, 2022 | 27,758 | 27,013 | 32,061 | 365,900 | (6,860) | (364,088) | 745 | |||||||||||||||||||||
| Loss for the year | (110,282) | (109,898) | (109,898) | (384) | ||||||||||||||||||||||||
| Other comprehensive income/(loss) for the year | (14,445) | (14,445) | (14,436) | (9) | ||||||||||||||||||||||||
| Total comprehensive income/(loss) for the year | (124,727) | (124,343) | (14,436) | (109,907) | (384) | |||||||||||||||||||||||
| Other changes in reserves | 0 | 0 | (1,845) | 1,845 | ||||||||||||||||||||||||
| Equity contribution (PIPE financing) and Transaction costs related to issuance of ordinary shares in exchange of Public Warrants | (955) | (955) | 0 | (955) | ||||||||||||||||||||||||
| Equity contribution (Private warrants exercise) and Issuance of shares in exchange of Public Warrants | 7,569 | 7,569 | 379 | 7,190 | ||||||||||||||||||||||||
| Share-based payment expenses | 11,032 | € 1 | € 0 | 11,032 | € 1 | € 0 | € 1 | € 80 | € 0 | € 0 | 11,032 | € (80) | 0 | |||||||||||||||
| Ending balance at Dec. 31, 2023 | (79,322) | (79,683) | 32,521 | 372,135 | (23,141) | (461,198) | 361 | |||||||||||||||||||||
| Loss for the year | (44,615) | (44,208) | (44,208) | (407) | ||||||||||||||||||||||||
| Other comprehensive income/(loss) for the year | 28,496 | 28,496 | 28,486 | 10 | ||||||||||||||||||||||||
| Total comprehensive income/(loss) for the year | (16,119) | (15,712) | 28,486 | (44,198) | (407) | |||||||||||||||||||||||
| Other changes in reserves | 0 | 0 | (1,365) | 1,365 | ||||||||||||||||||||||||
| Share-based payment expenses | (2,486) | € 0 | € 0 | (2,486) | € 0 | € 38 | € 242 | € 0 | € 0 | (2,486) | € (38) | € (242) | 0 | |||||||||||||||
| Ending balance at Dec. 31, 2024 | € (97,927) | € (97,881) | € 32,801 | € 372,135 | € 3,980 | € (506,797) | € (46) |
| X | ||||||||||
- Definition Increase Decrease Through Exchange Of Ordinary Shares No definition available.
|
| X | ||||||||||
- Definition Increase decrease through other changes in reserves. No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Total for all subsidiaries [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the conversion of convertible instruments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the exercise of warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase in equity through the issue of equity instruments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|